Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
Public ClinicalTrials.gov record NCT04489420. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) in Adults With Recurrent Glioblastoma Multiforme (GBM)
Study identification
- NCT ID
- NCT04489420
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Celularity Incorporated
- Industry
- Enrollment
- 3 participants
Conditions and interventions
Conditions
- Analgesics
- Analgesics, Non-narcotic
- Anti-infective Agents
- Antiviral Agents
- Astrocytoma, Grade IV
- Cyclophosphamide
- Giant Cell Glioblastoma
- Glioblastoma Multiforme
- Immunologic Factors
- Immunosuppressive Agents
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Physiological Effects of Drugs
- Sensory System Agents
Interventions
- CYNK001-IT Biological
- CYNK001-IV Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2020
- Primary completion
- Aug 9, 2021
- Completion
- Aug 9, 2021
- Last update posted
- Aug 9, 2022
2020 – 2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Univeristy of Texas MD ANderson Cancer Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04489420, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 9, 2022 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04489420 live on ClinicalTrials.gov.